Home Markets US FDA panel votes against first MDMA-based PTSD treatment US FDA panel votes against first MDMA-based PTSD treatment Andrew M Jun 05, 2024 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/fda-panel-to-review-psychedelic-drug-mdma-for-first-time-3469436 FDA Market Updates MDMA-based PTSD www.investing.com/news/stock-market-news/fda-panel-to-review-psychedelic-drug-mdma-for-first-time-3469436